GENOLOCKER Trademark

Trademark Overview


On Thursday, December 27, 2018, a trademark application was filed for GENOLOCKER with the United States Patent and Trademark Office. The USPTO has given the GENOLOCKER trademark a serial number of 88243325. The federal status of this trademark filing is SECTION 8 - ACCEPTED as of Tuesday, November 18, 2025. This trademark is owned by Shanghai LinkGen Biotech Co., Ltd.. The GENOLOCKER trademark is filed in the Medical Instrument Products category with the following description:

[ Surgical apparatus and instruments; ] Medical apparatus and instruments for monitoring vital signs, blood properties and respiratory events; Medical devices for obtaining body fluid samples; Medical specimen collection devices in the nature of glass slides, cups, bags for the collection of blood, urine, fecal matter; Medical diagnostic instruments for the analysis of body fluids
genolocker

General Information


Serial Number88243325
Word MarkGENOLOCKER
Filing DateThursday, December 27, 2018
Status701 - SECTION 8 - ACCEPTED
Status DateTuesday, November 18, 2025
Registration Number5860824
Registration DateTuesday, September 17, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 2, 2019

Trademark Statements


Goods and Services[ Surgical apparatus and instruments; ] Medical apparatus and instruments for monitoring vital signs, blood properties and respiratory events; Medical devices for obtaining body fluid samples; Medical specimen collection devices in the nature of glass slides, cups, bags for the collection of blood, urine, fecal matter; Medical diagnostic instruments for the analysis of body fluids

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateThursday, December 27, 2018
Primary Code010
First Use Anywhere DateSaturday, December 1, 2018
First Use In Commerce DateSaturday, December 1, 2018

Trademark Owner History


Party NameShanghai LinkGen Biotech Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressShanghai City 200120
CN

Party NameShanghai LinkGen Biotech Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDistrict, Shanghai 200050
CN

Party NameShanghai LinkGen Biotech Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDistrict, Shanghai 200050
CN

Trademark Events


Event DateEvent Description
Monday, December 31, 2018NEW APPLICATION ENTERED
Friday, January 18, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 19, 2019ASSIGNED TO EXAMINER
Thursday, March 21, 2019NON-FINAL ACTION WRITTEN
Thursday, March 21, 2019NON-FINAL ACTION E-MAILED
Thursday, March 21, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, April 9, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, April 14, 2019ASSIGNED TO LIE
Saturday, April 20, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, April 20, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, May 22, 2019FINAL REFUSAL WRITTEN
Wednesday, May 22, 2019FINAL REFUSAL E-MAILED
Wednesday, May 22, 2019NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, May 22, 2019TEAS REQUEST FOR RECONSIDERATION RECEIVED
Saturday, May 25, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, May 25, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, May 28, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 12, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 2, 2019PUBLISHED FOR OPPOSITION
Tuesday, July 2, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 17, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, September 17, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, July 18, 2025TEAS SECTION 8 RECEIVED
Monday, November 17, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, November 18, 2025REGISTERED - SEC. 8 (6-YR) ACCEPTED
Tuesday, November 18, 2025NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED